STO · ONCO.ST
Oncopeptides AB (publ)
SEK 1.67-SEK 0.04 (-2.22%)
Oncopeptides AB (publ)’s quoted price sits in the lower half of its reported 52-week range, 72.75% below the high.
Loading market information…
OTC · HITC · USD
Stock price, earnings
Quote as of May 5, 2025, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Healthcare Integrated Technologies, Inc.’s quoted price sits in the upper half of its reported 52-week range, 38.28% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Healthcare Integrated Technologies, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Healthcare Integrated Technologies, Inc. (HITC) specializes in crafting advanced technology solutions designed to seamlessly integrate and automate various facets of the healthcare industry, including continuing care, home care, and professional medical environments. Its flagship product, SafeSpace, offers an innovative ambient fall detection system specifically tailored for both residential and long-term care facilities. Beyond SafeSpace, the firm delivers a range of healthcare services and monitoring equipment for health and safety. It also provides comprehensive integrated solutions for the professional healthcare sector, encompassing electronic health records (EHR), remote patient monitoring, and telehealth functionalities. Further expanding its capabilities, Healthcare Integrated Technologies has forged a strategic alliance with Servant Rehab, focusing on delivering AI-powered fall prevention and rehabilitation therapies to the senior living demographic. Founded in 2013 and headquartered in Knoxville, Tennessee, the organization adopted its current name, Healthcare Integrated Technologies, Inc., in May 2018, having previously operated as Grasshopper Staffing, Inc.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:49 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
SEK 1.67-SEK 0.04 (-2.22%)
Oncopeptides AB (publ)’s quoted price sits in the lower half of its reported 52-week range, 72.75% below the high.
$4.03+$0.03 (+0.75%)
Biostage, Inc.’s quoted price sits in the lower half of its reported 52-week range, 55.22% below the high.
$0.54-$0.00 (-0.37%)
Mindset Pharma Inc.’s quoted price sits in the upper half of its reported 52-week range, 3.74% below the high.
$0.55-$0.01 (-1.1%)
MCI Onehealth Technologies Inc.’s quoted price sits in the upper half of its reported 52-week range, 33.47% below the high.
$0.82$0.00 (0.0%)
Medivir AB (publ)’s quoted price sits in the upper half of its reported 52-week range, 8.89% below the high.
$1.00$0.00 (0.0%)
Assisted 4 Living, Inc.’s quoted price sits in the lower half of its reported 52-week range, 66.67% below the high.
$1.96+$0.00 (0.0%)
MedPeer,Inc.’s quoted price sits in the lower half of its reported 52-week range, 100.0% below the high.
€1.18-€0.02 (-1.67%)
Herantis Pharma Oyj’s quoted price sits in the lower half of its reported 52-week range, 58.89% below the high.
